MENU
GNPX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Genprex (GNPX) Ownership - Who owns Genprex?

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes... Show more

Profile

Industry
Pharmaceuticals Major
Address
3300 Bee Cave Road
Phone
+1 877 774-4679
Employees
26
Web
https://www.genprex.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.45M
P/E Ratio
0.09
Total Cash
1.1M
Projected Growth
N/A
Total Debt
279.29K
Revenue
N/A
Risk (Beta)
-1.71
Dividend Yield
N/A
Total Cash/Share
0.49
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

GNPX
Capitalization
6.45M
P/E Ratio
0.09
Risk (Beta)
-1.71
Dividend Yield
N/A
Total Cash
1.1M
Total Cash/Share
0.49
Total Debt
279K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
768K
P/B Ratio
8.40
Cash Flow
N/A
Earnings
-1.26K
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
0.67
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-16.38M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-441.57
Shares Held By Institutions
179K
Shares Outstanding - Current
2.27M
Total Liabilities
2.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-92.391
View a ticker or compare two or three
GNPX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

a developer of molecular therapies for cancer treatment

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
3300 Bee Cave Road
Phone
+1 877 774-4679
Employees
26
Web
https://www.genprex.com